Caladrius SEC Filing | Lisata Therapeutics, Inc.

Filing date	Form	Description	View
Mar 17, 2017	DEFA14A	Additional proxy soliciting materials - definitive	View HTML 0001571049-17-002520.pdf 0001571049-17-002520.rtf 0001571049-17-002520.xls
Mar 17, 2017	DEFA14A	Additional proxy soliciting materials - definitive	View HTML 0001571049-17-002518.pdf 0001571049-17-002518.rtf 0001571049-17-002518.xls
Mar 17, 2017	8-K	Report of unscheduled material events or corporate event	View HTML 0001571049-17-002517.pdf 0001571049-17-002517.rtf 0001571049-17-002517.xls
Mar 17, 2017	8-K	Report of unscheduled material events or corporate event	View HTML 0001571049-17-002519.pdf 0001571049-17-002519.rtf 0001571049-17-002519.xls
Mar 17, 2017	8-K	Report of unscheduled material events or corporate event	View HTML 0000320017-17-000014.pdf 0000320017-17-000014.rtf 0000320017-17-000014.xls
Mar 17, 2017	DEFA14A	Additional proxy soliciting materials - definitive	View HTML 0000320017-17-000015.pdf 0000320017-17-000015.rtf 0000320017-17-000015.xls
Feb 14, 2017	SC 13G/A	An amendment to the SC 13G filing	View HTML 0001193125-17-042454.pdf 0001193125-17-042454.rtf 0001193125-17-042454.xls
Feb 8, 2017	4	Statement of changes in beneficial ownership of securities	View HTML 0001144204-17-006741.pdf 0001144204-17-006741.rtf 0001144204-17-006741.xls
Feb 6, 2017	4	Statement of changes in beneficial ownership of securities	View HTML 0001144204-17-006290.pdf 0001144204-17-006290.rtf 0001144204-17-006290.xls
Jan 31, 2017	4	Statement of changes in beneficial ownership of securities	View HTML 0001144204-17-005182.pdf 0001144204-17-005182.rtf 0001144204-17-005182.xls